Saltz L - Search Results

1

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.

Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, O'Reilly E, Schwartz G, DeGroff J, Gonzalez G, Kelsen DP. Ilson DH, et al. Among authors: saltz l. J Clin Oncol. 1999 Oct;17(10):3270-5. doi: 10.1200/JCO.1999.17.10.3270. J Clin Oncol. 1999. PMID: 10506629 Clinical Trial.

2

Combined-modality therapy in the treatment of local-regional esophageal cancer.

Saltz L, Kelsen D. Saltz L, et al. Ann Oncol. 1992 Dec;3(10):793-9. doi: 10.1093/oxfordjournals.annonc.a058098. Ann Oncol. 1992. PMID: 1286042 Free article. Review. No abstract available.

3

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V, Brennan M. Kelsen D, et al. Among authors: saltz l. J Clin Oncol. 1992 Apr;10(4):541-8. doi: 10.1200/JCO.1992.10.4.541. J Clin Oncol. 1992. PMID: 1548519 Clinical Trial.

4

Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.

Rusch VW, Niedzwiecki D, Tao Y, Menendez-Botet C, Dnistrian A, Kelsen D, Saltz L, Markman M. Rusch VW, et al. Among authors: saltz l. J Clin Oncol. 1992 Jun;10(6):1001-6. doi: 10.1200/JCO.1992.10.6.1001. J Clin Oncol. 1992. PMID: 1588364

5

Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: saltz l. J Clin Oncol. 1992 Aug;10(8):1218-24. doi: 10.1200/JCO.1992.10.8.1218. J Clin Oncol. 1992. PMID: 1634912 Clinical Trial.

6

Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.

Minsky BD, Cohen AM, Enker WE, Kelsen DP, Kemeny N, Riechman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: saltz l. Int J Radiat Oncol Biol Phys. 1992;22(1):139-45. doi: 10.1016/0360-3016(92)90993-r. Int J Radiat Oncol Biol Phys. 1992. PMID: 1727111 Clinical Trial.

7

Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: saltz l. J Clin Oncol. 1992 Jan;10(1):79-84. doi: 10.1200/JCO.1992.10.1.79. J Clin Oncol. 1992. PMID: 1727928

8

Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.

Kelsen D, Lovett D, Wong J, Saltz L, Buckley M, Murray P, Heelan R, Lightdale C. Kelsen D, et al. Among authors: saltz l. J Clin Oncol. 1992 Feb;10(2):269-74. doi: 10.1200/JCO.1992.10.2.269. J Clin Oncol. 1992. PMID: 1732428 Clinical Trial.

9

Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.

Minsky BD, Kemeny N, Cohen AM, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: saltz l. Cancer. 1991 Jun 1;67(11):2859-66. doi: 10.1002/1097-0142(19910601)67:11<2859::aid-cncr2820671126>3.0.co;2-w. Cancer. 1991. PMID: 2025851

10

A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies.

Saltz L, Kelsen D. Saltz L, et al. Cancer. 1990 Oct 15;66(8):1688-91. doi: 10.1002/1097-0142(19901015)66:8<1688::aid-cncr2820660806>3.0.co;2-k. Cancer. 1990. PMID: 2208023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters